Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 0 | 0 | 0 | 3,600 | 0 |
| Gross Profit | N/A | N/A | N/A | 3,600 | N/A |
| Operating Expenses | 31,109 | 34,529 | 33,065 | 33,839 | 33,940 |
| Operating Income | -31,109 | -34,529 | -33,065 | -30,239 | -33,940 |
| Other Income | 1,311 | 1,661 | 1,576 | 1,200 | 1,223 |
| Pre-tax Income | -29,798 | -32,868 | -31,489 | -29,039 | -32,717 |
| Income Tax | -1,133 | 17 | 21 | 17 | 19 |
| Net Income Continuous | -28,665 | -32,885 | -31,510 | -29,056 | -32,736 |
| Net Income | $-28,665 | $-32,885 | $-31,510 | $-29,056 | $-32,736 |
| EPS Basic Total Ops | -2.82 | -3.26 | -3.13 | -2.90 | -3.40 |
| EPS Basic Continuous Ops | -2.83 | -3.26 | -3.13 | -2.90 | -3.27 |
| EPS Diluted Total Ops | -2.82 | -3.26 | -3.13 | -2.90 | -3.40 |
| EPS Diluted Continuous Ops | -2.83 | -3.26 | -3.13 | -2.90 | -3.27 |
| EPS Diluted Before Non-Recurring Items | -2.30 | -3.30 | -3.10 | N/A | N/A |
| EBITDA(a) | $-30,200 | $-33,180 | $-32,246 | $-29,607 | $-32,831 |